Results 181 to 190 of about 28,292 (266)
Atrial arrhythmias related to antitumor treatment in patients with coronary heart disease and malignant tumors. [PDF]
Zhang B, Zhang L, Ren Y, Xu C.
europepmc +1 more source
Role of Neuroimaging Before Coronary Angiography in Patients With Out‐of‐Hospital Cardiac Arrest
ABSTRACT Background Patients presenting following out‐of‐hospital cardiac arrest (OOHCA) often require emergency coronary angiography. Presentations can be associated with syncope or head‐trauma. Aims We investigated the impact and utility of pre‐coronary angiography CT‐Brain (CT‐B) in patients following OOHCA on clinical outcomes.
Edmond Wong +8 more
wiley +1 more source
Efficacy evaluation of Wenxin Keli in treating anthracycline-induced atrial arrhythmias (WARMA study): protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial. [PDF]
Jiao L +10 more
europepmc +1 more source
[Arrhythmias caused by anti-arrhythmia agents].
E S, Platou, T, Skomedal
openaire +1 more source
ABSTRACT Guillain‐Barré syndrome with pandysautonomia can mimic neurodegenerative and cardiogenic conditions, particularly in elderly patients presenting with autonomic symptoms and parkinsonian features. Timely neurologic evaluation and ganglioside antibody testing—especially anti‐GM2—are essential for accurate diagnosis and the initiation of ...
Rua Alsaeed +3 more
wiley +1 more source
Latest Management of Cardiac Sarcoidosis: A Comprehensive Review. [PDF]
Alhareth D +4 more
europepmc +1 more source
Placental ischemia in pre‐eclampsia initiates cytokine‐driven endothelial dysfunction, angiogenic imbalance, oxidative stress, and thromboinflammation. Elevated TNF‐α, IL‐6, IL‐17, sFlt‐1, and complement activation promote vasoconstriction, thrombosis, and cardiovascular instability.
Emmanuel Ifeanyi Obeagu
wiley +1 more source
Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial. [PDF]
Segan L +25 more
europepmc +1 more source
Mesenchymal stem cell‐derived exosomes (MSC‐sEVs) show preclinical promise for cardiac repair via anti‐inflammatory, anti‐apoptotic, pro‐angiogenic and anti‐fibrotic effects. However, translational hurdles remain, including non‐standardized isolation, unvalidated potency assays, incomplete GMP manufacturing, and lack of completed Phase II/III trials ...
Sakhavat Abolhasani +2 more
wiley +1 more source

